Friday, October 18, 2024
HomeFinnacial"Brown Financial invests $331K in HealthEquity, Inc."

“Brown Financial invests $331K in HealthEquity, Inc.”

“`html

Several hedge funds have changed their investments in HealthEquity (HQY). Vanguard Group increased its stake by 1.7%, owning 8,768,632 shares valued at $715.8 million after adding 149,133 shares. Wasatch Advisors boosted their stake by 8.3% to 7,409,080 shares worth $604.8 million, acquiring an additional 569,249 shares. Motley Fool Asset Management raised its stake significantly by 3,001%, now holding 3,762,064 shares valued at $307.1 million after acquiring 3,640,748 shares. Clearbridge Investments increased their stake by 1.9%, owning 2,377,204 shares worth $204.9 million. Mackenzie Financial Corp raised its stake by 16.0%, owning 2,364,521 shares valued at $203.8 million. Institutional investors own 99.55% of the stock.

HealthEquity Stock Down 1.5%

HQY opened at $79.10. Key financial metrics include a current ratio of 4.10, quick ratio of 4.10, and a debt-to-equity ratio of 0.51. The company has a market cap of $6.88 billion with a P/E ratio of 85.98 and a beta of 0.52. Its 1-year low is $61.81 and high is $88.26.

HealthEquity recently reported quarterly earnings of $0.66 per share, beating estimates of $0.50. Revenue was $299.93 million, above expectations of $284.48 million. Analysts expect 2.25 earnings per share for this year.

Insider Transactions

Director Frank Corvino sold 7,705 shares on July 8 for $81.89, totaling $630,962.45. He now owns 6,070 shares valued at $497,072.30. Vice Chairman Stephen Neeleman sold 35,000 shares on July 25 for $79.86, totaling $2,795,100.00. Following this, he holds 89,769 shares valued at approximately $7.17 million. Corporate insiders own 2.20% of the stock.

Analyst Ratings

Analysts have generally positive views on HQY. Deutsche Bank raised its target price from $102 to $103 with a buy rating. Wells Fargo increased its target from $107 to $110. JMP Securities set a target of $105, and Bank of America reduced its target from $105 to $100 while maintaining a buy rating. Overall, analysts rate HQY as a Moderate Buy with an average target price of $103.83.

View Our Latest Stock Analysis on HQY

HealthEquity Company Profile

(Free Report) HealthEquity, Inc provides technology-enabled platforms for consumers and employers in the U.S., offering cloud-based services for health savings, bill payments, and investment choices.

See Also

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Subscribe for Daily HealthEquity News & Ratings – Enter your email to receive a daily summary of the latest news and ratings for HealthEquity and related companies with MarketBeat.com’s FREE daily newsletter.





“`

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments